Objective-To compare prescribing patterns between a group of fundholding practices and a group of non-fundholding practices in north east Scotland using a method which provides more accurate statements about volumes prescribed than standard NHS statistics.
Introduction
Along with the more widely publicised reforms of primary and secondary care services the opportunity for general practitioners to hold a budget was given official status by the 1990 white paper Working for Patients. '2 This became the basis of general practice fundholding, which started on 1 April 1991. Reports on the initial development of fundholding are now appearing,"-'0 although the consequences of the subsequent expansion of the scheme have yet to be properly monitored.
The main focus of the early published work on fundholding has been the provision and purchase of secondary care services. Although accounting for some 40% of the total fund, the prescribing element has been less discussed. Some research has attempted to incorporate population factors into calculating the prescribing fund, but allocation has been largely based on historic levels (Prescribing Research Unit, University of Leeds, unpublished report, 1992) . It has proved difficult to calculate an annual "uplift" to allow for inflation, varying drug prices, and the introduction of new and often expensive preparations. Prescribing analysis and cost (PACT) data in England and its Scottish equivalent, Scottish prescribing analysis (SPA), provide information at the level of cost per patient. The analyses of volumes of drug prescribed are limited by being presented either in terms of "prescribed items" with no allowance being made for the quantity of drug in each item or in listings of prescriptions of different quantity and strengths which cannot conveniently be aggregated. Thus although PACT/ SPA data are of some use at practice level, their value to managers and researchers is limited.
The World Health Organisation defined daily dose system allows conversion of prescribed substances into equivalent units of a standard defined volume.'" In a joint project with the Nordic Council on Medicines the WHO Centre for Drug Collaboration Statistics has agreed appropriate defined daily doses for most substances commonly used in primary care.'2 Their anatomical, therapeutic, chemical (ATC) classification system is well established'3 14 and was originally created to facilitate international comparison of drugs covering both individual substances and combined preparations. The defined daily doses for a particular substance can be located in the Anatomical, Therapeutic, Chemical Manual." Recent work has shown how this type ofmeasure can be adapted to allow comparisons of use across time for one class of drugs (antibiotics) .
I
In our study we used the defined daily dose system to compare trends in volume and cost between fundholding and control practices over two years.
Methods

DEFINED DAILY DOSES
The original Nordic version of the defined daily dose system was adapted for use in this study by an experienced pharmacist to reflect practice in the United Kingdom. The highest proportion of elderly patients, there was no correlation between age and estimated or actual spend in the other five groups. The uplift in fund negotiated for the second year of fundholding ranged from 2% to 16% and did not appear to be related to actual spend or percentage saved or overspent in the previous period.
TRENDS IN PRESCRIBING COST AND VOLUME Table II compares trends between the Tayside fundholding group, the five Grampian fundholding groups aggregated as one, and the group of six control practices. The cost per patient per year fell by 2-9% between period 1 and period 3 in Tayside while rising by 9-8% and 12-6% in the Grampian fundholding and control practices respectively. However, Tayside fundholders spent £8.30 per patient (34%) more than Grampian fundholders in period 1. By period 3 this differential had been reduced to £5 (19%). The Grampian fundholders spent £1.75 (8%) more than the control group in period 1; by period 3 this differential had also reduced to £1.30 (5%). When these data were converted to defined daily doses per patient there was a progressive fall in volume in all three practice groupings across the three time periods.
In particular the control practices showed an overall fall of 9% despite starting from a lower initial level. From 15 practices ranked in order of the proportion of their patients aged over 65. The third of practices with the most elderly patients prescribed a significantly more defined daily doses than the third with the least (69-0
Discussion
This paper is one of a series reporting an evaluation of the first general practice fundholding project in the Grampian and Tayside areas of Scotland. It is based on a study of a geographically distinct cohort of 53 fundholding and 40 control doctors. The difficulty of defining a good control group for fundholding research is shown by the fact that during the course of this study all the control practices decided to apply to become, and have now become, fundholders. Comparisons between test and control groups must therefore be interpreted with caution. Given the analytical limitations of PACT/SPA data we have developed the WHO defined daily dose method of examining prescribing information, and a byproduct of this study has been the demonstration that future thinking about measuring Costper defined daily dose (C) BMJ VOLUME 307 Table I shows the wide variation of funds set on the basis of historic prescribing cost. The absence of a consistent relation between the funds set and either the actual spending or the age mix of the practices shows the need to find a better process for fund allocation. In addition, the equity implications of practices of 10 000 patients receiving allocations differing by as much as £200 000 on the basis of historical activity alone needs to be addressed with some urgency. Table V shows large variations in volume levels within British National Formulary sections as well as a relation between age and volume for some sections. The table allows individual practices to identify areas where their volumes differ from the mean. This mean defined daily dose per patient could be taken as a target volume for each British National Formulary section which practices could aim to direct their prescribing behaviour towards. For those sections related to age a mean can be calculated for each of the three age bands presented. For example, for diuretics the target volumes for the three age bands shown in the table and based on proportion of patients aged 65 or over would be 13-6, 12-1, and 9-1 defined daily doses. A similar method could be used to calculate cost per volume targets.
The analysis we have described should be further developed on a regional basis. At this level other demographic factors could be incorporated in the calculation of a range of volume targets across British National Formulary sections. With a larger number of practices the balance between historic pattems and regional targets should be more easily achieved. The result would be fund allocations which are more equitable than at present and could be used for all practices, whether fundholding or not. This would BMJ VOLUME 307 confirm the move away from regarding cost per patient as the principal determinant of budgets.
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Restoration ofa brilliant mind
She was in her 80s, a distinguished elderly academic who had been a regular visitor to our outpatient department with her advancing osteoporosis. She enjoyed the hospital waiting room, engaging herself deeply in conversation about old Bermondsey with random neighbours or commenting on the distinguished persons, commemorated on the plaques on the walls, many of whom she or her family had known personally and socially. I was startled to realise that almost two years must have passed since I had last seen her when her general practitioner telephoned me with the sad news that she was "on the way out," confused, short of breath, and confined to her armchair and bed. Her ancient nanny had died a few weeks before and she was alone in her dark old apartment. Could we admit her to make her last few days more comfortable? Her once brilliant mind was unravelled indeed. Pallid, wild eyed, and breathing with great difficulty she seemed to be in extremis. Since nanny died her calories had come mainly from her substantial stock of good clarets. Her pallor had a lemon tint and her pernicious anaemia was promptly diagnosed and confirmed. A large retrosternal goitre explained much of her respiratory difficulty and her accompanying hypothyroidism also contributed to the diagnostic complex.
More balanced nutrition with liberal vitamins, vitamin B-12 by injection, careful thyroxin replacement, and the passage of time saw a miraculous transformation. The proof of cure was the manuscript that, four months later, she prepared and submitted to a learned journal. I treasure my now yellowing copy which contains her paper, much of it drawn from her own memory, experiences, and research. Closely argued, it cast new light on a well known Victorian historical episode.
I had seen reversible dementia in the elderly before and I have seen it since but that extraordinary restoration of a brilliant human mind was one of my more unforgettable clinical experiences and the substance of much passionate teaching thereafter.-HARRY KEEN is emeritus professor of medicine in London
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